Figure 1.

Flow diagram of participants with plasma samples available for nicotinamide phosphoribosyltransferase (NAMPT) analysis at their baseline, 3‐month, and 6‐month clinic visits. Gray boxes indicate participants for which samples at the subsequent clinic visit were unavailable for analysis.